Ruili Ji, Jiaqi Zhang, Dan Liang, Hongbing Quan, Yue Wu, Aiping Peng, Weili Li, Shaofang Lu, Xuedong Zhang, Changwen Ke, Dawei Wang, Jianhua Xu
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been used worldwide on a large scale because of its potent ability to contain the coronavirus disease 2019 (COVID-19) pandemic, and the antibody response induced by the vaccine needs to be elucidated. Thus, we conducted a prospective trial in healthy subjects to observe the antibody response after three doses of inactivated vaccines. Our results showed that neutralizing antibody (NAb) levels were significantly higher after the booster vaccination compared to the second, a 4...
September 29, 2023: Viral Immunology